Upload Avatar (500 x 500)
Yongping Ma
Basic Medical Sciences
Chongqing Medical University
Chongqing
Language: English, Chinese
Cancer
Therapy
Targeted
Tumor
Immunology
Biochemistry
Molecular Biology
Gene Therapy
Research
Innovation
Areas of Focus
- Tumor Targeted Therapy
- Immunology
Work Experience
- 2010.04-present - Chongqing Medical University, PI at Molecular Medicine and Oncology Research Center
- 2009.04-2010.04 - Visiting Scholar at NIAID, NIH (USA)
- 2005.06-2009.03 - Deputy Director, Associate Professor, Professor at Chongqing Medical University
- 2000.07-2002.08 - Lecturer at Chongqing Medical University
- 1989.07-1995.08 - Teacher at Gansu Province Dangchang County Shawan Middle School
Academic Background & Achievements
- 2002.09-2005.06 PhD in Clinical Laboratory Diagnostics: Chongqing Medical University
- 1997.09-2000.06 MSc in Microbiology: Wuhan University
- 1995.09-1997.06 Bachelor's in English Education: Gansu Education College
- 1986.09-1989.07 Diploma in Biology: Tianshui Normal School
- First Chongqing Young and Middle-aged Backbone Teacher
- Leader in Biochemistry and Molecular Biology in Chongqing
- China Industry-University-Research Cooperation Innovation Award
Publications
- Deciphering the rule of antigen-antibody amino acid interaction, Jiang M#, Fang C#, Ma Y*, 2023
- Bifidobacterium infantis-Mediated Herpes Simplex Virus-TK/Ganciclovir Treatment Inhibits Cancer Metastasis in Mouse Model, Wang C#, Shen Y#, Ma Y*, 2023
- Peripheral Blood Genes Crosstalk between COVID-19 and Sepsis, Fang C, Ma Y*, 2023
- Prognosis Risk Model Based on Pyroptosis-Related lncRNAs for Gastric Cancer, Jiang M#, Fang C#, Ma Y*, 2023
- Ultrasensitive electrochemical biosensor for des-gamma-carboxy prothrombin analysis based on core-shell Pd@PtCu-alloy loaded on WS2 nanosheet, Xuhuai Fu, Xinmin Li, Daobin Han, Wei Yang, Changjin Liu, Lu Fan, Shijia Ding, Yongping Ma*, 2021
- Quantitative Proteomic Analysis of Escherichia coli Heat-Labile Toxin B Subunit (LTB) with Enterovirus 71 (EV71) Subunit VP1, Liu L, Ma Y*, Zhou H, Wu M, 2016
- Bifidobacterial recombinant thymidine kinase-ganciclovir gene therapy system induces FasL and TNFR2 mediated antitumor apoptosis in solid tumors, Wang C, Ma Y*, Hu Q, Xie T, Wu J, Zeng F, Song F, 2016
- Intravenous Administration Is an Effective and Safe Route for Cancer Gene Therapy Using the Bifidobacterium-Mediated Recombinant HSV-1 Thymidine Kinase and Ganciclovir, Zhou H, He Z, Wang C, Xie T, Liu L, Liu C, Song F, Ma Y*, 2016
- Recent advances in nontoxic Escherichia coli heat-labile toxin and its derivative adjuvants, Ma Y*, 2016
- Identification of G and P genotype-specific motifs in the predicted VP7 and VP4 amino acid sequences, Ma Y*, 2015
- Cloning and nucleotide sequence analyses of 11 genome segments of two American and one British equine rotavirus strains, Ma Y*, Wen X, Hoshino Y, Yuan L, 2015
- Construction of Bifidobacterium infantis as a live oral vaccine that expresses antigens of the major fimbrial subunit (CfaB) and the B subunit of heat-labile enterotoxin (LTB) from enterotoxigenic Escherichia coli, Ma Y*, Luo Y, Huang X, Song F, Liu G, 2012
Awards
- 2002: Second Prize for Scientific and Technological Progress, New Efficient Viral Composite Biological Insecticide
- 2004: First Chongqing Young and Middle-aged Backbone Teacher
- 2008: Reserve Candidate for Academic and Technical Leader in Biochemistry and Molecular Biology
- 2009: Third Prize for Scientific and Technological Progress, Basic Research on Cervical Cancer Gene Therapy
- 2009: Second Prize for Higher Education Teaching Achievement, Comprehensive Reform of Basic Medical Experimental Teaching System
- 2020: China Industry-University-Research Cooperation Innovation Award
